Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 2
2016 2
2017 2
2018 2
2019 1
2020 6
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

13 results
Results by year
Filters applied: . Clear all
Page 1
Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma.
Saltarella I, Desantis V, Melaccio A, Solimando AG, Lamanuzzi A, Ria R, Storlazzi CT, Mariggiò MA, Vacca A, Frassanito MA. Saltarella I, et al. Among authors: melaccio a. Cells. 2020 Jan 9;9(1):167. doi: 10.3390/cells9010167. Cells. 2020. PMID: 31936617 Free PMC article. Review.
High-Risk Multiple Myeloma: Integrated Clinical and Omics Approach Dissects the Neoplastic Clone and the Tumor Microenvironment.
Solimando AG, Da Vià MC, Cicco S, Leone P, Di Lernia G, Giannico D, Desantis V, Frassanito MA, Morizio A, Delgado Tascon J, Melaccio A, Saltarella I, Ranieri G, Ria R, Rasche L, Kortüm KM, Beilhack A, Racanelli V, Vacca A, Einsele H. Solimando AG, et al. Among authors: melaccio a. J Clin Med. 2019 Jul 9;8(7):997. doi: 10.3390/jcm8070997. J Clin Med. 2019. PMID: 31323969 Free PMC article. Review.
Halting the vicious cycle within the multiple myeloma ecosystem: blocking JAM-A on bone marrow endothelial cells restores the angiogenic homeostasis and suppresses tumor progression.
Solimando AG, Da Vià MC, Leone P, Borrelli P, Croci GA, Tabares P, Brandl A, Di Lernia G, Bianchi FP, Tafuri S, Steinbrunn T, Balduini A, Melaccio A, De Summa S, Argentiero A, Rauert-Wunderlich H, Frassanito MA, Ditonno P, Henke E, Klapper W, Ria R, Terragna C, Rasche L, Rosenwald A, Kortüm KM, Cavo M, Ribatti D, Racanelli V, Einsele H, Vacca A, Beilhack A. Solimando AG, et al. Among authors: melaccio a. Haematologica. 2020 Apr 30:haematol.2019.239913. doi: 10.3324/haematol.2019.239913. Online ahead of print. Haematologica. 2020. PMID: 32354870 Free article.
Anti-VEGF Drugs in the Treatment of Multiple Myeloma Patients.
Ria R, Melaccio A, Racanelli V, Vacca A. Ria R, et al. Among authors: melaccio a. J Clin Med. 2020 Jun 6;9(6):1765. doi: 10.3390/jcm9061765. J Clin Med. 2020. PMID: 32517267 Free PMC article. Review.
MicroRNAs-Based Nano-Strategies as New Therapeutic Approach in Multiple Myeloma to Overcome Disease Progression and Drug Resistance.
Desantis V, Saltarella I, Lamanuzzi A, Melaccio A, Solimando AG, Mariggiò MA, Racanelli V, Paradiso A, Vacca A, Frassanito MA. Desantis V, et al. Among authors: melaccio a. Int J Mol Sci. 2020 Apr 27;21(9):3084. doi: 10.3390/ijms21093084. Int J Mol Sci. 2020. PMID: 32349317 Free PMC article. Review.
Effect of thyroidectomy on circulating angiogenic cytokines in papillary thyroid carcinoma and benign goiter: Potential for new biomarkers?
Ria R, Prete F, Melaccio A, Di Meo G, Saltarella I, Solimando AG, Gurrado A, Ferraro V, Pasculli A, Sgaramella LI, Racanelli V, Vacca A, Testini M. Ria R, et al. Among authors: melaccio a. Surgery. 2021 Jan;169(1):27-33. doi: 10.1016/j.surg.2020.03.031. Epub 2020 May 30. Surgery. 2021. PMID: 32482341 Free article.
Vγ9Vδ2 T Cells as Strategic Weapons to Improve the Potency of Immune Checkpoint Blockade and Immune Interventions in Human Myeloma.
Castella B, Melaccio A, Foglietta M, Riganti C, Massaia M. Castella B, et al. Among authors: melaccio a. Front Oncol. 2018 Nov 6;8:508. doi: 10.3389/fonc.2018.00508. eCollection 2018. Front Oncol. 2018. PMID: 30460198 Free PMC article. Review.
Right Heart Changes Impact on Clinical Phenotype of Amyloid Cardiac Involvement: A Single Centre Study.
Cicco S, Solimando AG, Buono R, Susca N, Inglese G, Melaccio A, Prete M, Ria R, Racanelli V, Vacca A. Cicco S, et al. Among authors: melaccio a. Life (Basel). 2020 Oct 18;10(10):247. doi: 10.3390/life10100247. Life (Basel). 2020. PMID: 33081052 Free PMC article.
Functional and Biological Role of Endothelial Precursor Cells in Tumour Progression: A New Potential Therapeutic Target in Haematological Malignancies.
Reale A, Melaccio A, Lamanuzzi A, Saltarella I, Dammacco F, Vacca A, Ria R. Reale A, et al. Among authors: melaccio a. Stem Cells Int. 2016;2016:7954580. doi: 10.1155/2016/7954580. Epub 2015 Dec 14. Stem Cells Int. 2016. PMID: 26788072 Free PMC article. Review.
Subcutaneous immunoglobulins in patients with multiple myeloma and secondary hypogammaglobulinemia: a randomized trial.
Vacca A, Melaccio A, Sportelli A, Solimando AG, Dammacco F, Ria R. Vacca A, et al. Among authors: melaccio a. Clin Immunol. 2018 Jun;191:110-115. doi: 10.1016/j.clim.2017.11.014. Epub 2017 Nov 28. Clin Immunol. 2018. PMID: 29191714 Clinical Trial.
13 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback